Search Results - "Stebbins, Christopher"

Refine Results
  1. 1
  2. 2

    Immunogenicity for antisense oligonucleotides: a risk-based assessment by Stebbins, Christopher C, Petrillo, Marco, Stevenson, Lauren F

    Published in Bioanalysis (01-11-2019)
    “…The specificity and application of ASOs have been broadly demonstrated in both animal models and humans for various disease targets (9), resulting in the…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Vav1 Dephosphorylation by the Tyrosine Phosphatase SHP-1 as a Mechanism for Inhibition of Cellular Cytotoxicity by Stebbins, Christopher C., Watzl, Carsten, Billadeau, Daniel D., Leibson, Paul J., Burshtyn, Deborah N., Long, Eric O.

    Published in Molecular and Cellular Biology (01-09-2003)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  6. 6

    Essential Role of LAT in T Cell Development by Zhang, Weiguo, Sommers, Connie L, Burshtyn, Deborah N, Stebbins, Christopher C, DeJarnette, Jan B, Trible, Ronald P, Grinberg, Alexander, Tsay, Henry C, Jacobs, Helena M, Kessler, Craig M, Long, Eric O, Love, Paul E, Samelson, Lawrence E

    Published in Immunity (Cambridge, Mass.) (01-03-1999)
    “…The linker molecule LAT is a substrate of the tyrosine kinases activated following TCR engagement. Phosphorylated LAT binds many critical signaling molecules…”
    Get full text
    Journal Article
  7. 7

    Cutting Edge: NK Cell Inhibitory Receptors Prevent Tyrosine Phosphorylation of the Activation Receptor 2B4 (CD244) by Watzl, Carsten, Stebbins, Christopher C, Long, Eric O

    Published in The Journal of immunology (1950) (01-10-2000)
    “…Abstract 2B4 is an NK cell activation receptor that can provide a costimulatory signal to other activation receptors and whose mode of signal transduction is…”
    Get full text
    Journal Article
  8. 8

    Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158) by Long, Eric O., Barber, Domingo F., Burshtyn, Deborah N., Faure, Mathias, Peterson, Mary, Rajagopalan, Sumati, Renard, Valéry, Sandusky, Mina, Stebbins, Christopher C., Wagtmann, Nicolai, Watzl, Carsten

    Published in Immunological reviews (01-06-2001)
    “…The killer cell immunoglobulin‐like receptor (KIR) family includes receptors that bind to HLA class I molecules on target cells and inhibit natural killer…”
    Get full text
    Journal Article
  9. 9

    Randomized Phase IIa Clinical Study of an Anti-αvβ6 Monoclonal Antibody in Idiopathic Pulmonary Fibrosis by Raghu, Ganesh, Mouded, Majd, Prasse, Antje, Stebbins, Christopher, Zhao, Guolin, Song, Guochen, Arefayene, Million, Violette, Shelia M, Gallagher, Diana, Gibson, Kevin F

    “…Patients with IPF typically tolerated the once-weekly subcutaneous treatment of BG00011 at doses less than 1.0 mg/kg well in this short phase lla research…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Adapting dried blood spot sampling for an anti-therapeutic antibody immunogenicity assay by Xiang, Yuhong, Welch, Mackenzie, Amaravadi, Lakshmi, Stebbins, Christopher

    Published in Journal of immunological methods (31-07-2013)
    “…Dried blood spot sampling is a microvolume sampling technique with many potential advantages. It allows for easier handling and less expensive shipment and…”
    Get full text
    Journal Article
  15. 15

    2018 White Paper on Recent Issues in Bioanalysis: focus on flow cytometry, gene therapy, cut points and key clarifications on BAV (Part 3 - LBA/cell-based assays: immunogenicity, biomarkers and PK assays) by Stevenson, Lauren, Richards, Susan, Pillutla, Renuka, Torri, Albert, Kamerud, John, Mehta, Devangi, Keller, Stephen, Purushothama, Shobha, Gorovits, Boris, Litwin, Virginia, Stebbins, Christopher, Marini, Joseph, Beaver, Chris, Sperinde, Gizette, Siguenza, Patricia, Staack, Roland F, Qiu, Yongchang, Amaravadi, Lakshmi, Amur, Shashi, Fleener, Catherine Aversa, Baltrukonis, Daniel, Catlett, Ian, Cherry, Elana, Chung, Shan, Cludts, Isabelle, Donato, Lorella Di, Fischer, Saloumeh, Fraser, Stephanie, Garofolo, Fabio, Green, Cherie, Gunn, George, Haidar, Sam, Haulenbeek, Jonathan, Henderson, Neil, Hopper, Shirley, Ishii-Watabe, Akiko, Islam, Rafiq, Janelsins, Brian, Jawa, Vibha, Kakkanaiah, Vellalore, Kamondi, Szilard, Kolaitis, Gerry, Kubiak, Robert J, Kumar, Seema, Kurki, Pekka, Liang, Meina, Liu, Patrick, Maxfield, Kimberly, Myler, Heather, Palackal, Nisha, Palmer, Rachel, Pedras-Vasconcelos, João, Piccoli, Steven, Rhyne, Paul, Saito, Yoshiro, Savoie, Natasha, Schick, Eginhard, Schweighardt, Becky, Shih, Judy, Song, An, Sriraman, Priya, Staelens, Ludovicus, Sumner, Giane, Sun, Yongliang, Ullmann, Martin, Verthelyi, Daniela, Wadhwa, Meenu, Wang, Yow-Ming, Xu, Yuanxin, Yan, Haoheng, Yang, Tong-yuan, Zeng, Rong

    Published in Bioanalysis (01-12-2018)
    “…The 2018 12 Workshop on Recent Issues in Bioanalysis took place in Philadelphia, PA, USA on April 9-13, 2018 with an attendance of over 900 representatives…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Natural Killer Cells and Mast Cells from gp49B Null Mutant Mice Are Functional by Rojo, Susana, Stebbins, Christopher C., Peterson, Mary E., Dombrowicz, David, Wagtmann, Nicolai, Long, Eric O.

    Published in Molecular and Cellular Biology (01-10-2000)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Adhesion to target cells is disrupted by the killer cell inhibitory receptor by Burshtyn, Deborah N., Shin, Jiyeon, Stebbins, Christopher, Long, Eric O.

    Published in Current biology (29-06-2000)
    “…Killer cell immunoglobulin-like receptors (KIR) inhibit the cytotoxic activity of natural killer (NK) cells by recruitment of the tyrosine phosphatase SHP-1 to…”
    Get full text
    Journal Article
  20. 20

    Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules by Katz, J F, Stebbins, C, Appella, E, Sant, A J

    Published in The Journal of experimental medicine (01-11-1996)
    “…We have studied the consequences of invariant chain (Ii) and DM expression on major histocompatibility complex (MHC) class II function. Ii has a number of…”
    Get full text
    Journal Article